TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer
Authors
Keywords
-
Journal
World Journal of Gastrointestinal Oncology
Volume 11, Issue 7, Pages 551-566
Publisher
Baishideng Publishing Group Inc.
Online
2019-07-15
DOI
10.4251/wjgo.v11.i7.551
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Integrating TYMS, KRAS and BRAF testing in patients with metastatic colorectal cancer
- (2017) Anastasios Ntavatzikos et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer
- (2016) Frank A. Sinicrope et al. Clinical Gastroenterology and Hepatology
- Global patterns and trends in colorectal cancer incidence and mortality
- (2016) Melina Arnold et al. GUT
- Prognostic Effect ofBRAFandKRASMutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab
- (2016) Julien Taieb et al. JAMA Oncology
- Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials
- (2016) Lizhen Zhu et al. PLoS One
- Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer
- (2015) T T Seppälä et al. BRITISH JOURNAL OF CANCER
- Prognostic and predictive significance of thymidylate synthase protein expression in non-small cell lung cancer: A systematic review and meta-analysis
- (2015) Qingyun Liu et al. Cancer Biomarkers
- KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancer
- (2015) Yanhong Deng et al. Molecular Oncology
- Prognostic value ofKRASandBRAFmutations in curatively resected colorectal cancer
- (2015) Shigenori Kadowaki WORLD JOURNAL OF GASTROENTEROLOGY
- Reply to ‘Letter to the Editor of Annals of Surgical Oncology Concerning “Robotic versus Open Pancreatectomy: A Systematic Review and Meta-Analysis”,’ by Petrucciani Niccolò, et al. (ASO-2013-09-1427)
- (2014) Jie Zhang et al. ANNALS OF SURGICAL ONCOLOGY
- Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic study
- (2014) M-C Etienne-Grimaldi et al. BRITISH JOURNAL OF CANCER
- Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis
- (2014) Dan Rosmarin et al. JOURNAL OF CLINICAL ONCOLOGY
- Thymidylate synthase genetic polymorphisms and colorectal cancer risk: A meta-analysis
- (2014) Jun Wang et al. Clinics and Research in Hepatology and Gastroenterology
- Thymidylate Synthase Gene Polymorphism and Survival of Colorectal Cancer Patients Receiving Adjuvant 5-Fluorouracil
- (2013) Violetta Sulzyc-Bielicka et al. Genetic Testing and Molecular Biomarkers
- Effect of Adjuvant Chemotherapy on Survival of Patients With Stage III Colon Cancer Diagnosed After Age 75 Years
- (2012) Hanna K. Sanoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Thymidylate synthase and thymidine phosphorylase mRNA expression in primary lesions using laser capture microdissection is useful for prediction of the efficacy of FOLFOX treatment in colorectal cancer patients with liver metastasis
- (2012) KENSUKE KUMAMOTO et al. Oncology Letters
- Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803
- (2011) S. Ogino et al. CLINICAL CANCER RESEARCH
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
- (2011) Gordon Hutchins et al. JOURNAL OF CLINICAL ONCOLOGY
- Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil
- (2011) Marina Vignoli et al. PHARMACOLOGICAL RESEARCH
- TS gene polymorphisms are not good markers of response to 5-FU therapy in stage III colon cancer patients
- (2011) A. Fariña-Sarasqueta et al. CELLULAR ONCOLOGY
- Liposomal pegylated doxorubicin and oxaliplatin as salvage chemotherapy in patients with metastatic gastric cancer treated earlier
- (2010) Francesco Recchia et al. ANTI-CANCER DRUGS
- Colorectal cancer
- (2010) David Cunningham et al. LANCET
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy
- (2009) Ioannis Kostopoulos et al. BMC CANCER
- KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803
- (2009) S. Ogino et al. CLINICAL CANCER RESEARCH
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
- Relationship of polymorphism of the tandem repeat sequence in the thymidylate synthase gene and the survival of stage III colorectal cancer patients receiving adjuvant 5-flurouracil-based chemotherapy
- (2009) Chi-Min Park et al. JOURNAL OF SURGICAL ONCOLOGY
- Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance
- (2009) R. Humeniuk et al. MOLECULAR CANCER THERAPEUTICS
- Identification of genes conferring resistance to 5-fluorouracil
- (2009) B. K. Yoo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Thymidylate synthase genotypes and tumour regression in stage II/III rectal cancer patients after neoadjuvant fluorouracil-based chemoradiation
- (2008) Jan Stoehlmacher et al. CANCER LETTERS
- Ras oncogenes: split personalities
- (2008) Antoine E. Karnoub et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started